Adage Capital Partners
MGNX icon

Adage Capital Partners’s MacroGenics MGNX Stock Holding History

Adage Capital Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-370,000
Closed -$11.8M – 1046
2021
Q1 		$11.8M Buy
+370,000
New +$8.99M 0.02% 626
2020
Q3 		– Sell
-500,000
Closed -$14M – 794
2020
Q2 		$14M Buy
+500,000
New +$8.69M 0.04% 473

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Adage Capital Partners's MGNX Position: Q2 2021 in Review

Adage Capital Partners sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 370,000 shares — an estimated $11.8M sold.

Adage Capital Partners first reported a position in MGNX in Q2 2020 and held it in 2 quarters. The position peaked at $14M in Q2 2020. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Adage Capital Partners reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Adage Capital Partners sold 370,000 MacroGenics shares in Q2 2021, an estimated $11.8M.
  • Adage Capital Partners first reported a position in MacroGenics in Q2 2020 and held it in 2 quarters.
  • Adage Capital Partners's MacroGenics position peaked at $14M in Q2 2020.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.